ph-Responsive Alendronic Acid-Coated Liposomes for Improved Treatment Osteosarcoma
Main Article Content
Abstract
Objective
Current research work aimed to develop pH-responsive osteosarcoma-targeted liposomes composed of non-oncology drugs previously identified for repositioning purposes.
Material and Methods
Using thin film hydration method, the Ketoconazole (KCZ)-, Simvastatin (SVN)-, and Niclosamide (NSD)-loaded non-targeted liposomes (KLs, SLs, and NLs respectively) were developed individually. The Aledronic acid-Choleteryl hemiscuccinate conjugate (AA-CHSC) was synthesized and confirmed using FTIR and 1H-NMR analysis. The AA-CHSC coated liposomes (pH sensitive and targeted liposome: PT-KLs, PT-SLs, and PT-NLs) were developed individually for the treatment of osteosarcoma with improved efficacy and reduced drug’s primary effects. The developed non-targeted and targeted liposomes were characterized for drug contentt,vesicle size, surface morphology using transmission electron microscope (TEM), in vitro pH-sensitive drug release behaviour using dialysis bag technique, and in vitro cytotoxicity characteristics against osteosarcoma cells.
Results
All non-targeted liposomes showed %drug content and mean vesicle size in the range of 41-75% and 161-182 nm, respectively. The AA-CHSC insertion into the liposomal membrane (targeted liposomes) has substantially improved the drug solubility in the membrane as a result of its amphiphilic nature. Furthermore, the targeted liposomes showed moderately increased mean vesicle size (203-210 nm) validating the surface modification. The TEM image revealed the formation of spherical, nearly spherical, and non-aggregated liposomes. The AA-CHSC insertion also caused liposomes sensitive to tumor pH (5.8); as a result, substantially higher drug release (58-80%) was observed as compared to non-targeted liposomes (34-52%). The cytotoxicity study results revealed substantially higher osteosarcoma cell (Saos-2) growth inhibition characteristics of targeted liposomes.
Conclusions
In conclusion, the developed targeted liposomes have potential application in the treatment of osteosarcoma. In addition, detailed anticancer activities should be revealed for the combination of targeted liposomes as the combination caused almost similar cytotoxicity as that of individual targeted liposomes.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Lindsey BA, Markel JE, Kleinerman ES. Osteosarcoma overview. Rheumatology and therapy. 2017 Jun; 4:25-43.
Cabrera-Andrade A, López-Cortés A, Jaramillo-Koupermann G, González-Díaz H, Pazos A, Munteanu CR, Pérez-Castillo Y, Tejera E. A multi-objective approach for anti-osteosarcoma cancer agents’ discovery through drug repurposing. Pharmaceuticals. 2020 Nov 22;13(11):409.
Omer N, Le Deley MC, Piperno-Neumann S, Marec-Berard P, Italiano A, Corradini N, Bellera C, Brugieres L, Gaspar N. Phase-II trials in osteosarcoma recurrences: a systematic review of past experience. European Journal of Cancer. 2017 Apr 1;75:98-108.
Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert review of anticancer therapy. 2018 Jan 2;18(1):39-50.
Kumbhar P, Kole K, Yadav T, Bhavar A, Waghmare P, Bhokare R, Manjappa A, Jha NK, Chellappan DK, Shinde S, Singh SK. Drug repurposing: An emerging strategy in alleviating skin cancer. European Journal of Pharmacology. 2022 Jul 5;926:175031.
Kumbhar P, Manjappa A, Shah R, Jha NK, Singh SK, Dua K, Disouza J, Patravale V. Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges. Journal of Controlled Release. 2022 Jan 1;341:1-5.
Patil OB, Manjappa AS, Kumbhar PS, Bhosale SP, Disouza JI, Salawi A, Sambamoorthy U. Development of stable self-nanoemulsifying composition and its nanoemulsions for improved oral delivery of non-oncology drugs against hepatic cancer. OpenNano. 2022 Jul 1;7:100044.
Kumbhar P, Kole K, Khadake V, Marale P, Manjappa A, Nadaf S, Jadhav R, Patil A, Singh SK, Dua K, Jha NK. Nanoparticulate drugs and vaccines: breakthroughs and bottlenecks of repurposing in breast cancer. Journal of Controlled Release. 2022 Sep 1;349:812-30.
Deshantri AK, Moreira AV, Ecker V, Mandhane SN, Schiffelers RM, Buchner M, Fens MH. Nanomedicines for the treatment of hematological malignancies. Journal of Controlled Release. 2018 Oct 10;287:194-215.
Deshantri AK, Fens MH, Ruiter RW, Metselaar JM, Storm G, Mandhane SN, Graat GH, Lentjes EG, Yuan H, de Bruijn JD, Mutis T. Complete tumor regression by liposomal bortezomib in a humanized mouse model of multiple myeloma. HemaSphere. 2020 Oct;4(5).
Sambamoorthy U, Manjappa AS, Eswara BR, Sanapala AK, Nagadeepthi N. Vitamin E oil incorporated liposomal melphalan and simvastatin: approach to obtain improved physicochemical characteristics of hydrolysable melphalan and anticancer activity in combination with simvastatin against multiple myeloma. AAPS PharmSciTech. 2022 Jan;23:1-6..
Rommasi F, Esfandiari N. Liposomal nanomedicine: applications for drug delivery in cancer therapy. Nanoscale Research Letters. 2021 May 25;16(1):95.
Sambamoorthy U, Manjappa AS, Eswara BR, Sanapala AK, Nagadeepthi N. Vitamin E oil incorporated liposomal melphalan and simvastatin: approach to obtain improved physicochemical characteristics of hydrolysable melphalan and anticancer activity in combination with simvastatin against multiple myeloma. AAPS PharmSciTech. 2022 Jan;23:1-6..
Unnam S, Manjappa AS, Eswara BR, Salawi A, Gunti P. Liposomal Melphalan: Approach to obtain improved plasma stability, pharmacokinetics, and in vitro and in vivo anticancer efficacy in combination with liposomal simvastatin against mouse RPMI-8226 multiple myeloma model. Journal of Drug Delivery Science and Technology. 2022 Jul 1; 73:103479.
Nadaf SJ, Killedar SG. Curcumin nanocochleates: Use of design of experiments, solid state characterization, in vitro apoptosis and cytotoxicity against breast cancer MCF-7 cells. Journal of Drug Delivery Science and Technology. 2018 Oct 1;47:337-50.
Galatage ST, Trivedi R, Bhagwat DA. Oral self-emulsifying nanoemulsion systems for enhancing dissolution, bioavailability and anticancer effects of camptothecin. Journal of Drug Delivery Science and Technology. 2022 Dec 1;78:103929..
Bandgar SA, Jadhav NR, Manjappa AS. A remarkable in vitro cytotoxic, cell cycle arresting and proapoptotic characteristics of low-dose mixed micellar simvastatin combined with alendronate sodium. Drug delivery and translational research. 2020 Aug; 10:1122-35.
Peram MR, Jalalpure S, Kumbar V, Patil S, Joshi S, Bhat K, Diwan P. Factorial design-based curcumin ethosomal nanocarriers for the skin cancer delivery: in vitro evaluation. Journal of liposome research. 2019 Jul 3;29(3):291-311.
Galatage ST, Manjappa AS, Bhagwat DA, Trivedi R, Salawi A, Sabei FY, Alsalhi A. Oral self-nanoemulsifying drug delivery systems for enhancing bioavailability and anticancer potential of fosfestrol: In vitro and in vivo characterization. European Journal of Pharmaceutics and Biopharmaceutics. 2023 Dec 1; 193:28-43.
Galatage ST, Manjappa AS, Bhagwat DA, Trivedi R, Salawi A, Sabei FY, Alsalhi A. Oral self-nanoemulsifying drug delivery systems for enhancing bioavailability and anticancer potential of fosfestrol: In vitro and in vivo characterization. European Journal of Pharmaceutics and Biopharmaceutics. 2023 Dec 1; 193:28-43.
Galatage ST, Trivedi R, Bhagwat DA. Characterization of camptothecin by analytical methods and determination of anticancer potential against prostate cancer. Future Journal of Pharmaceutical Sciences. 2021 May 22;7(1):104.
Ju C, Zhang C. Preparation and Characterization of pH Sensitive Drug Liposomes. Liposome-Based Drug Delivery Systems. 2021:385-408.
Patil OB, Manjappa AS, Kumbhar PS, Bhosale SP, Disouza JI, Salawi A, Sambamoorthy U. Development of stable self-nanoemulsifying composition and its nanoemulsions for improved oral delivery of non-oncology drugs against hepatic cancer. OpenNano. 2022 Jul 1;7:100044.
Mast MP, Modh H, Knoll J, Fecioru E, Wacker MG. An Update to Dialysis-Based Drug Release Testing—Data Analysis and Validation Using the Pharma Test Dispersion Releaser. Pharmaceutics. 2021 Nov 25;13(12):2007.
Manjappa AS, Kumbhar PS, Kasabe R, Diwate SK, Disouza JI. Ameliorated in vitro anticancer efficacy of methotrexate D-α-tocopheryl polyethylene glycol 1000 succinate ester against breast cancer cells. Future Journal of Pharmaceutical Sciences. 2019 Dec;5:1-0.
Yadav P, Rastogi V, Verma A. Application of Box–Behnken design and desirability function in the development and optimization of self-nanoemulsifying drug delivery system for enhanced dissolution of ezetimibe. Future Journal of Pharmaceutical Sciences. 2020 Dec;6(1):1-20.
Kumar G, Mullick P, Nandakumar K, Mutalik S, Rao CM. Box–Behnken Design-Based Development and Validation of a Reverse-Phase HPLC Analytical Method for the Estimation of Paclitaxel in Cationic Liposomes. Chromatographia. 2022 Jul;85(7):629-42.
Singh V, Haque S, Niwas R, Srivastava A, Pasupuleti M, Tripathi C. Strategies for fermentation medium optimization: an in-depth review. Frontiers in microbiology. 2017 Jan 6;7:2087.
Jankovic A, Chaudhary G, Goia F. Designing the design of experiments (DOE)–An investigation on the influence of different factorial designs on the characterization of complex systems. Energy and Buildings. 2021 Nov 1;250:111298..
Unnisa A, Chettupalli AK, Alazragi RS, Alelwani W, Bannunah AM, Barnawi J, Amarachinta PR, Jandrajupalli SB, Elamine BA, Mohamed OA, Hussain T. Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations. Pharmaceuticals. 2023 Aug 14;16(8):1151.
Chaudhari KR, Kumar A, Khandelwal VK, Ukawala M, Manjappa AS, Mishra AK, Monkkonen J, Murthy RS. Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel. Journal of controlled release. 2012 Mar 28;158(3):470-8.
Hirabayashi H, Takahashi T, Fujisaki J, Masunaga T, Sato S, Hiroi J, Tokunaga Y, Kimura S, Hata T. Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS). Journal of controlled release. 2001 Jan 29;70(1-2):183-91.
Hosain F, Spencer RP, Couthon HM, Sturtz GL. Targeted delivery of antineoplastic agent to bone: biodistribution studies of technetium-99m-labeled gem-bisphosphonate conjugate of methotrexate. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 1996 Jan 1;37(1):105-7.
Jing C, Li B, Tan H, Zhang C, Liang H, Na H, Chen S, Liu C, Zhao L. Alendronate-decorated nanoparticles as bone-targeted alendronate carriers for potential osteoporosis treatment. ACS Applied Bio Materials. 2021 May 19;4(6):4907-16.
Yamauchi M, Tsutsumi K, Abe M, Uosaki Y, Nakakura M, Aoki N. Release of drugs from liposomes varies with vesicle size. Biological and Pharmaceutical Bulletin. 2007;30(5):963-6.
Olusanya TO, Haj Ahmad RR, Ibegbu DM, Smith JR, Elkordy AA. Liposomal drug delivery systems and anticancer drugs. Molecules. 2018 Apr 14;23(4):907.
Nunes SS, Miranda SE, de Oliveira Silva J, Fernandes RS, de Alcântara Lemos J, de Aguiar Ferreira C, Townsend DM, Cassali GD, Oliveira MC, de Barros AL. pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment. Biomedicine & Pharmacotherapy. 2021 Dec 1; 144:112317.
Silva JO, Fernandes RS, Lopes SC, Cardoso VN, Leite EA, Cassali GD, Marzola MC, Rubello D, Oliveira MC, de Barros AL. pH-sensitive, long-circulating liposomes as an alternative tool to deliver doxorubicin into tumors: a feasibility animal study. Molecular imaging and biology. 2016 Dec; 18:898-904.
Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: Structure, composition, types, and clinical applications. Heliyon. 2022 May 1.
Nunes SS, Fernandes RS, Cavalcante CH, da Costa César I, Leite EA, Lopes SC, Ferretti A, Rubello D, Townsend DM, de Oliveira MC, Cardoso VN. Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes. Drug delivery and translational research. 2019 Feb 15; 9:123-30.
Nunes SS, Fernandes RS, Cavalcante CH, da Costa César I, Leite EA, Lopes SC, Ferretti A, Rubello D, Townsend DM, de Oliveira MC, Cardoso VN. Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes. Drug delivery and translational research. 2019 Feb 15; 9:123-30.